Who owns the IVRA trademark?

The IVRA trademark is owned by Apotex Inc..

What class is the IVRA trademark registered in?

The IVRA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for IVRA?

The USPTO serial number for IVRA is 98747709.

What is the registration number for IVRA?

IVRA is registered under USPTO registration number 8471566.

Sealvo

Home Search: IVRAIVRA #98747709

Back

Updated Oct 7, 2026·9 searches this week

View on USPTO TSDR Find similar marks

IVR

USPTO Trademark Record

REGISTERED

IVRA

SN 98747709·Reg 8471566·Filed Sep 12, 2024

Owner Apotex Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

IVRA (Serial No. 98747709), Registration No. 8471566, is a registered US trademark filed on Sep 12, 2024 by Apotex Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: September 29, 2032

Mark Intelligence

IVRA (Reg. #8471566) is a registered US trademark that has been protecting its owner, Apotex Inc., since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 12, 2024

SERIAL

98747709

REG#

8471566

REGISTERED

Sep 29, 2026

Filing Information

StatusREGISTERED

Filing DateSep 12, 2024

Serial Number98747709

Registration No.8471566

Registration DateSep 29, 2026

Status DateSep 29, 2026

Published for OppositionApr 08, 2025

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: May 08, 2025

First use in commerce: May 08, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

30 events

REGISTERED-PRINCIPAL REGISTER

Sep 29, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 29, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ASSIGNED TO LIE

Sep 08, 2026

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 08, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 08, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 08, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 08, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 03, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

May 14, 2026

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

May 14, 2026

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

SOU TEAS EXTENSION RECEIVED

May 14, 2026

SOU TEAS EXTENSION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Mar 23, 2026

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Mar 23, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 23, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jan 08, 2026

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 07, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 03, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

USE AMENDMENT FILED

Jul 02, 2025

USE AMENDMENT FILED

SOU EXTENSION 1 FILED

Jul 02, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jul 02, 2025

SOU EXTENSION 1 GRANTED

TEAS STATEMENT OF USE RECEIVED

Jul 02, 2025

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

Jul 02, 2025

SOU TEAS EXTENSION RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 03, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 08, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 08, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 02, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO EXAMINER

Mar 13, 2025

ASSIGNED TO EXAMINER

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 13, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

NEW APPLICATION ENTERED

Sep 12, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 12, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Apotex Inc.

Additional USPTO filings from the same owner.

APO

APOTEX

73162271

APOTEX INC.

REGISTERED

APO

APOBIOLOGIX

86634783

APOTEX INC.

REGISTERED

APO

APOBIOLOGIX

85926345

APOTEX INC.

REGISTERED

76535727

APOTEX INC.

REGISTERED

Other Marks by Jessica G. Kraver

Additional USPTO filings handled by the same attorney of record.

SHA

SHARPSYNC

99466711

REGISTERED

APO

APOTEX

73162271

REGISTERED

MEN

MENOPAUSE RELIEF THAT WORKS WITH YOUR BODY – NOT AGAINST IT

99045788

REGISTERED

NOC

NOCTERA

98759343

REGISTERED

IVRA

Run a conflict check

Other Marks by Apotex Inc.

Other Marks by Jessica G. Kraver

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company